X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RVNC

Closed

Revance The

3.65
0.00 (0.00%)
Last Update: 07 Feb 2025 00:00:00
Yesterday: 3.65
Day's Range: 0. - 0.
Send
When Written:
 
31.47
Revance Therapeutics is a biotechnology company that develops and commercializes innovative products for the aesthetic and therapeutic markets. The company's proprietary technology platform, called the RHA® Collection, is designed to create a more natural-looking aesthetic result by mimicking the natural movements of facial muscles. Revance's lead product candidate, DaxibotulinumtoxinA for Injection (DAXI), is a next-generation neuromodulator that has the potential to be a longer-lasting alternative to existing botulinum toxin products. The company is also developing a range of other products, including injectable dermal fillers, topical skincare products, and treatments for various medical conditions. Revance is headquartered in Newark, California, and was founded in 2002.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X